Less Ads, More Data, More Tools Register for FREE

Pin to quick picksM P Evans Regulatory News (MPE)

Share Price Information for M P Evans (MPE)

Share Price is delayed by 15 minutes
Get Live Data
1,512.00    -38.00 (-2.45%)
Bid:
1,510.00
Ask:
1,514.00
Spread: 4.00 (0.265%)
Market Cap: £788.72m
MPE Live PriceLast checked at - London Stock Exchange

Intraday M P Evans Share Chart

Crop and production

20 Jan 2025 07:00

RNS Number : 8580T
M. P. Evans Group PLC
20 January 2025
Β 

M. P. EVANS GROUP PLC

("THE GROUP")2024 crop and production

M.P. Evans Group PLC, a producer of sustainable Indonesian palm oil, is pleased to announce the following crop and production information for the year ended 31 December 2024:

2024

IncreaseΒ 

(decrease)

2023

Tonnes

%Β 

Tonnes

Crop of fresh fruit bunches ("ffb")

Own crops

937,000

2Β 

922,900

Scheme-smallholder crops

285,900

3Β 

278,500

Independent crops purchased

386,000

(8)

421,500

1,608,900

(1)

1,622,900

Production*

Crude palm oil ("CPO")

372,200

(2)

378,500

Palm kernels ("PK")

81,300

1Β 

80,600

*- figures include production from the Group's crop sold to third-party mills.

Crop levels across Indonesia, as a whole in 2024, were adversely affected by dry weather conditions in the latter part of the preceding year and, unusually, the country is likely to report a decrease in total output for the year. Against this backdrop, the Group is pleased to report a small increase in the crop harvested from the enlarged area managed by it during the year which, when combined with purchases from independent suppliers, resulted in a very similar total crop for processing of 1.6 million tonnes.

The Group received an average mill-gate price for its CPO of US$823 per tonne in 2024, 13% higher than the US$729 in the previous year. Prices were particularly robust in the second half, with dispatches averaging approximately US$950 per tonne in the last two months of the year. This high price environment continued to have a positive effect on the Group's revenue and profitability, as reported in the Group's announcement on 15 November 2024. Whilst prices have recently eased from these higher levels, sales in the early part of 2025 continue to be at higher than the 2024 average price.

The Group remains committed to operating sustainably, and all six of the Group's palm-oil mills now sell certified sustainable palm oil. More information is available in the Group's environmental, social and governance ('ESG') report available via the Group's website. In addition, the Group was pleased to receive an upgraded score of 88.9% in the November 2024 ESG policy transparency assessment conducted by the Zoological Society of London.

The Group continued to be highly profitable and cash generative during 2024, and these resources were put to good use as the Group allocated capital towards continuing growth, maintaining its financial strength, and offering attractive returns to its investors. The Group has an unbroken track record spanning more than thirty years of maintaining or increasing its annual dividend and, considering its crop and production figures for the year, the CPO price environment, and the Group's strong operating cash flows resulting therefrom, the board remains committed to this policy.

M.P. Evans chairman, Peter Hadsley-Chaplin, commented: "The Group has, once again, delivered excellent operational results in 2024, notwithstanding some weather-related challenges during the year. Combining this with the robust price environment, the Group will deliver a strong result for 2024, enabling it, as a responsible palm-oil producer focused on excellence, to recommit to its strategic priorities to deliver continuing growth and an increasing yield."

Enquiries:

M.P. Evans Group PLC

Telephone: +44 (0) 1892 516333

Peter Hadsley-Chaplin, chairman Matthew Coulson, chief executiveLuke Shaw, chief financial officer

Β 

Cavendish Capital Markets (Nomad and broker)

Telephone: +44 (0) 20 7220 0500

Matt Goode, George Lawson (Corporate finance)

Tim Redfern, Harriet Ward (ECM)

Β 

Hudson Sandler

Telephone: +44 (0) 20 7796 4133

Charlie Jack, Kerrigan, Francesca Rosser

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCGRGDBLGBDGUI
Date   Source Headline
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:30 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTransaction in Own Shares
28th May 20267:00 amRNSTransaction in Own Shares
26th May 20262:42 pmRNSShare Buyback Programme
20th May 202611:26 amRNSIndonesian commodity exporting
12th May 20262:52 pmRNSAGM Arrangements
1st Apr 20265:40 pmRNS2025 Annual Report
26th Mar 202610:16 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSFinal Results 2025
5th Mar 20267:00 amRNSNotice of Results
23rd Jan 20267:00 amRNSDirector/PDMR Shareholding
22nd Jan 20267:00 amRNS2025 Crop and production
16th Jan 20261:05 pmRNSDirector/PDMR Shareholding
6th Jan 20267:00 amRNSDirector/PDMR Shareholding
18th Dec 20257:00 amRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 202512:58 pmRNSPublication of 2024 ESG report
2nd Dec 20251:14 pmRNSCompany update
1st Dec 20257:00 amRNSAppointment of joint broker
10th Nov 20257:00 amRNSStrong pricing during second half of 2025
28th Oct 20255:33 pmRNSHolding(s) in Company
22nd Sep 20253:26 pmRNSAIM Rule 20
15th Sep 20257:00 amRNSHalf-year Report
27th Aug 20257:00 amRNSNotice of interim results & investor presentation
29th Jul 20257:00 amRNSPublication of TCFD report
24th Jul 20257:00 amRNS2025 H1 crop and production
14th Jul 202510:07 amRNSAcquisition
7th Jul 20254:54 pmRNSDirector/PDMR Shareholding
30th Jun 20254:30 pmRNSTotal Voting Rights
25th Jun 202511:18 amRNSIssue of Equity
18th Jun 20257:00 amRNSShare buyback programme
13th Jun 20251:45 pmRNSResult of AGM
13th Jun 20257:00 amRNSAGM Statement
12th Jun 20254:50 pmRNSAppointment to board roles
5th Jun 20257:00 amRNSAGM update
14th May 20257:00 amRNSDirectorate Change
22nd Apr 20255:33 pmRNSDirector/PDMR Shareholding
16th Apr 202511:00 amRNSAcquisition
31st Mar 20254:02 pmRNSPosting of Annual Report
25th Mar 20257:00 amRNSFinal Results
21st Mar 20257:00 amRNSDirector retirement
5th Mar 20257:00 amRNSNotice of Results and investor presentation
20th Jan 20253:05 pmRNSDirector/PDMR Shareholding
20th Jan 20257:00 amRNSCrop and production
2nd Jan 202511:31 amRNSDirector/PDMR Shareholding
2nd Jan 20257:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.